We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Experts: Protect Brand Biologics by Filing Range of Patents
Experts: Protect Brand Biologics by Filing Range of Patents
May 29, 2009
Drugmakers seeking to protect their products from follow-on biologics (FOBs) and biosimilars in case Congress creates a pathway for their approval should seek a range of patents on their products with staggered expiration dates, legal experts advise.